• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区药店心房颤动的早期检测-CRIFAFARMA 研究。

Early Detection of Atrial Fibrillation in Community Pharmacies-CRIFAFARMA Study.

机构信息

Department of Clinical Medicine, 541992Miguel Hernández University, San Juan de Alicante, Spain.

出版信息

J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221078973. doi: 10.1177/10742484221078973.

DOI:10.1177/10742484221078973
PMID:35200057
Abstract

BACKGROUND

Atrial fibrillation (AF) is the most common arrhythmia to appear in clinical practice. People with AF have 5 times the risk of stroke compared to the general population.

OBJECTIVE

This study aimed to determine the prevalence of AF in people over the age of 50 without known AF, who presented to a community pharmacy to check their cardiovascular risk factors, to identify risk factors associated with AF, and to assess the risk of stroke in people who screened positive for AF.

METHODS

A multicenter observational descriptive study of a screening program took place from May to December 2016. A blood pressure monitor (Microlife Watch BP Home) was used to screen for AF, and the CHA2DS2-VASc questionnaire was used to assess stroke risk.

RESULTS

The study included 452 adults over the age of 50. The CRIFAFARMA study detected a prevalence of AF of 9.1%. Risk factors for AF were: age of 75 years or older ( = .024), lack of physical activity ( = .043), diabetes ( < .001), dyslipidemia ( = .003), and history of cardiovascular disease ( = .003). Diabetes (OR 2.79, = .005) and dyslipidemia (OR 2.16, = .031) had a combined explanatory capacity in the multivariable logistic regression model adjusted for age. 85% were at high risk of stroke according to the CHA2DS2-VASc scale.

CONCLUSIONS

AF was detected in more than 9% of the included population. Factors associated with AF were advanced age, lack of physical activity, diabetes, dyslipidemia, and history of cardiovascular disease, with diabetes and dyslipidemia standing out as the factors with independent explanatory capacity.

摘要

背景

心房颤动(AF)是临床实践中最常见的心律失常。与普通人群相比,AF 患者发生中风的风险增加 5 倍。

目的

本研究旨在确定在没有已知 AF 的情况下,年龄在 50 岁以上、到社区药房检查心血管危险因素的人群中 AF 的患病率,确定与 AF 相关的危险因素,并评估 AF 筛查阳性人群的中风风险。

方法

2016 年 5 月至 12 月进行了一项多中心观察性描述性筛查研究。使用血压监测仪(Microlife Watch BP Home)筛查 AF,使用 CHA2DS2-VASc 问卷评估中风风险。

结果

本研究纳入了 452 名年龄在 50 岁以上的成年人。CRIFAFARMA 研究发现 AF 的患病率为 9.1%。AF 的危险因素包括:年龄 75 岁或以上( =.024)、缺乏体力活动( =.043)、糖尿病( <.001)、血脂异常( =.003)和心血管疾病史( =.003)。在调整年龄的多变量逻辑回归模型中,糖尿病(OR 2.79, =.005)和血脂异常(OR 2.16, =.031)具有联合解释能力。根据 CHA2DS2-VASc 量表,85%的人中风风险较高。

结论

在所纳入的人群中,超过 9%的人患有 AF。与 AF 相关的因素包括年龄较大、缺乏体力活动、糖尿病、血脂异常和心血管疾病史,其中糖尿病和血脂异常是具有独立解释能力的因素。

相似文献

1
Early Detection of Atrial Fibrillation in Community Pharmacies-CRIFAFARMA Study.社区药店心房颤动的早期检测-CRIFAFARMA 研究。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221078973. doi: 10.1177/10742484221078973.
2
Opportunistic Screening for Atrial Fibrillation in the Pharmacies: A Population-Based Cross-Sectional Study.药房中房颤的机会性筛查:一项基于人群的横断面研究。
High Blood Press Cardiovasc Prev. 2019 Aug;26(4):339-344. doi: 10.1007/s40292-019-00334-4. Epub 2019 Aug 5.
3
Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting.在真实世界的基层医疗环境中,自动血压测量设备Microlife WatchBP Home A用于心房颤动筛查的诊断性能。
BMJ Open. 2017 Jun 15;7(6):e013685. doi: 10.1136/bmjopen-2016-013685.
4
Feasibility of Atrial Fibrillation Screening With Mobile Health Technologies at Pharmacies.利用移动健康技术在药房进行房颤筛查的可行性
J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):142-151. doi: 10.1177/1074248419879089. Epub 2019 Oct 2.
5
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.通过在药房使用iPhone心电图进行社区心房颤动筛查来预防中风的可行性和成本效益。SEARCH-AF研究。
Thromb Haemost. 2014 Jun;111(6):1167-76. doi: 10.1160/TH14-03-0231. Epub 2014 Apr 1.
6
CHA2DS2-VASc score can guide the screening of atrial fibrillation - cross-sectional study in a geriatric ward.CHA2DS2-VASc 评分可指导心房颤动筛查——老年病房的横断面研究。
Clin Interv Aging. 2019 May 14;14:879-887. doi: 10.2147/CIA.S206976. eCollection 2019.
7
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.通过单次筛查检测到的心房颤动的估计中风风险、检出率和筛查所需人数:对 141220 名筛查个体的多国患者水平荟萃分析。
PLoS Med. 2019 Sep 25;16(9):e1002903. doi: 10.1371/journal.pmed.1002903. eCollection 2019 Sep.
8
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
9
Curricular-driven screening for atrial fibrillation at community pharmacies.社区药房基于课程的心房颤动筛查。
J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):541-545.e1. doi: 10.1016/j.japh.2021.10.017. Epub 2021 Oct 23.
10
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.伴有和不伴有心房颤动的患者的脑白质疏松症与卒中复发风险
Neurology. 2015 Mar 24;84(12):1213-9. doi: 10.1212/WNL.0000000000001402. Epub 2015 Feb 18.